Jinsheng Chen

JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia

Carl L. Manthey, Dana L. Johnson, Carl R. Illig et al. · Molecular Cancer Therapeutics · 2009 · 107 citations

Medicine, Oncology, Pharmacology +17

Discovery of novel FMS kinase inhibitors as anti-inflammatory agents

Carl R. Illig, Jinsheng Chen, Mark J. Wall et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

The role of glucocorticoids in increasing cardiovascular risk

Hai‐Wei Deng, Wei‐Yi Mei, Qing Xu et al. · Frontiers in Cardiovascular Medicine · 2023 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitors

Sanath K. Meegalla, Hui Huang, Carl R. Illig et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Human glioma stem-like cells induce malignant transformation of bone marrow mesenchymal stem cells by activating TERT expression

Yaodong Zhao, Jinsheng Chen, Xingliang Dai et al. · Oncotarget · 2017 · 12 citations · Full text

Medicine, Cell Biology, Oncology +13